Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Solazyme Launches Partnership with Versalis to Commercialize Encapso(TM)

Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and bioproducts company, and Versalis, the chemical subsidiary of Eni S.p.A., one of the world’s largest oil and gas companies, today announced a partnership to expand the commercial use of Encapso™ – the world’s first commercially-available, biodegradable encapsulated lubricant for drilling fluids.

“As a leading chemical company with a demonstrated commitment to green chemistry and an emerging focus on specialty oilfield products, Versalis is extremely well-positioned to advance the use of Encapso globally to provide customers with a high-performance and sustainable drilling lubricant,” said Solazyme CEO Jonathan Wolfson. “Through this partnership, we look forward to working closely with Versalis to expand into new markets to help meet the growing demand for energy while reducing impacts on our environment.”

Part of a leading oil and gas company and operating internationally with a dedicated distribution network, Versalis will expand market access and drive global sales for Encapso as a high-performance and sustainable drilling fluid additive. Versalis’ initial emphasis for Encapso will be oil and gas fields operated by its parent company Eni, which represent a significant amount of the world’s petroleum drilling activity. Encapso will be featured as part of the company’s recently launched Specialty Oilfield Chemicals product portfolio with target sales volumes exceeding 3,000 metric tons of Encapso annually.

Winner of the Presidential Green Chemistry Challenge Award, Solazyme launched Encapso in the Spring of 2014. With its unique, on-demand lubricant delivery system, Encapso increases rates of penetration, decreases drag and reduces both rotational torque and friction in a variety of vertical and horizontal drilling applications. This can lead to reduced drilling costs and accelerated operations. Developed from Solazyme’s technology platform, Encapso is non-hazardous and biodegradable.

Encapso’s effectiveness has been demonstrated commercially in more than 30 oil wells in basins across the United States and Canada, including major areas of exploration in the Williston Basin, Denver-Julesburg Basin, Permian Basin and Western Canada. Encapso’s versatility and inert shell makes it re-usable across various formulations and applications – further reducing overall customer costs.

About Solazyme

Solazyme, Inc. (Nasdaq: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost, plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into four target markets: (1) fuels and chemicals, (2) nutrition, (3) encapsulated lubricants and (4) consumer products.

Solazyme®, Encapso™, the Solazyme logo and Encapso logo and other trademarks or service names are the trademarks of Solazyme, Inc.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Solazyme, including statements that involve risks and uncertainties concerning: its commercialization and production plans; the commercialization plans of Solazyme’s products through the announced partnership; expectations regarding the manufacture of Solazyme’s products and the expansion of and access to new markets for Solazyme’s products. When used in this press release, the words “will”, “expects”, “intends” and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: Solazyme’s limited operating history; Solazyme’s limited experience in manufacturing commercial products at scale at its manufacturing facilities; the performance and adoption of and demand for Solazyme’s products in the marketplace; its ability to enter into and maintain strategic collaborations; and the historical volatility in the market for oil field services and products. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme.

In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q, as updated from time to time, for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release.

Solazyme, Inc.
Genet Garamendi, 650-780-4777
VP of Communications
Press@solazyme.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today